Patent · US Active

Compositions and methods for MYC messenger RNA inhibitors

US11306312B2 · kind B2 · utility

0Cited by
7References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 31, 2018
Grant dateApr 19, 2022
Priority date
Expiry dateDec 1, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods of making and using MYC mRNA antisense inhibitors. In a particular embodiment, the invention features compositions and methods useful for the treatment of a condition (e.g., cancer).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.